Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05524545
Title A Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors ALX Oncology Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.